Herold, K. C., Pescovitz, M. D., McGee, P., Krause-Steinrauf, H., Spain, L. M., Bourcier, K., . . . Dosch, H. M. (2011). Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in Type 1 diabetes.
Style de citation ChicagoHerold, Kevan C., et al. Increased T Cell Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (rituximab) Therapy in Type 1 Diabetes. 2011.
Style de citation MLAHerold, Kevan C., et al. Increased T Cell Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (rituximab) Therapy in Type 1 Diabetes. 2011.
Attention : ces citations peuvent ne pas être correctes à 100%.